Clinical Trial Update: Effect of Iron Therapy as an Adjunct to Epoetin Alfa in the Anemia of Cancer Chemotherapy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether adding iron therapy to epoetin alfa improves anemia in cancer patients receiving chemotherapy. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• Epogen (epoetin alfa) (epoetin alfa)
• Iron therapy (iron)

Snippet

Sponsor: Watson Pharmaceuticals | Conditions: Anemia | Phase 4 | Status: COMPLETED